Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20650471 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
Condition: Type 1 Diabetes
Interventions: Drug: Terbutaline;   Other: 20% basal insulin reduction;   Other: Control
2 Recruiting The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: G-Pen Mini™ (glucagon injection);   Other: Glucose Tabs;   Other: Basal Insulin Reduction

Study has passed its completion date and status has not been verified in more than two years.